Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity.

Read more: https://web.musc.edu/about/news-center/2024/08/01/drug-developed-for-pancreatic-cancer-shows-promise-against-most-aggressive-form-of-medulloblastoma